EUVIMEDEUVIMED entdecken
Übersichtsarbeit

Cervical Cancer

Vikrant V Sahasrabuddhe

Hematology/Oncology Clinics of North America · 2024-08 · 38 (4) · 771-781

DOI: 10.1016/j.hoc.2024.03.005 ↗

Kurz gefasst

Übersichtsarbeit in der Zeitschrift Hematology/Oncology Clinics of North America, 2024-08. Verfasst von Vikrant V Sahasrabuddhe. Beteiligte Einrichtung: Breast and Gynecologic Cancer Research Group, Division of Cancer Prevention, National Cancer Institute, National Institutes of Health, 9609 Medical C…. Hauptthemen laut MEDLINE: Uterine Cervical Neoplasms, Papillomavirus Infections, Early Detection of Cancer. Die Arbeit wurde bisher 63-mal zitiert (Crossref) und nennt 61 Literaturangaben. Gefördert von: U.S. Department of Health and Human Services, National Institutes of Health, National Cancer Institute.

AbstractSchlagwörterBibliografische AngabenZitierenVerwandte Studien

Abstract (Originalsprache)

Cervical cancer, caused due to oncogenic types of human papillomavirus (HPV), is a leading preventable cause of cancer morbidity and mortality globally. Chronic, persistent HPV infection-induced cervical precursor lesions, if left undetected and untreated, can progress to invasive cancer. Cervical cancer screening approaches have evolved from cytology (Papanicolaou test) to highly sensitive HPV-based molecular methods and personalized, risk-stratified, management guidelines. Innovations like self-collection of samples to increase screening access, innovative triage methods to optimize management of screen positives, and scalable and efficacious precancer treatment approaches will be key to further enhance the utility of prevention interventions.

Schlagwörter

MeSH-Schlagwörter (MEDLINE)

Uterine Cervical NeoplasmsPapillomavirus InfectionsEarly Detection of CancerHumansFemalePapillomaviridaePrecancerous Conditions

Stichwörter der Autor:innen

Cervical cancerHuman papillomavirus (HPV)Pap smearsScreen-and-treatScreeningSelf-collectionTestingVaccines

Autor:innen und Institutionen

  • Breast and Gynecologic Cancer Research Group, Division of Cancer Prevention, National Cancer Institute, National Institutes of Health, 9609 Medical Center Drive, Room 5E-338, Rockville, MD, USA. Electronic address: vikr…

Förderung

  • U.S. Department of Health and Human Services
  • National Institutes of Health
  • National Cancer Institute

Zitieren

APA

Sahasrabuddhe, V. V. (2024). Cervical Cancer. Hematology/Oncology Clinics of North America, 38(4), 771-781. https://doi.org/10.1016/j.hoc.2024.03.005

Vancouver

Sahasrabuddhe VV. Cervical Cancer. Hematology/Oncology Clinics of North America. 2024;38(4):771-781. doi:10.1016/j.hoc.2024.03.005

BibTeX
@article{Sahasrabuddhe2024,
  author = {Sahasrabuddhe, Vikrant V},
  title = {Cervical Cancer},
  journal = {Hematology/Oncology Clinics of North America},
  year = {2024},
  volume = {38},
  number = {4},
  pages = {771--781},
  doi = {10.1016/j.hoc.2024.03.005}
}
Kostenlos starten →